Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I could be misremembering, but I think avg for Elite has been closer to 3 months. I’ll try to look at history this weekend.
You think it will be filed that quickly? I was expecting late Nov/Dec, again, only if results were positive.
Holding ground much better than I would have anticipated without the BE results disclosure. Enjoy the near and mid-term ride.
No, I don’t think so. Baseline will be higher and continue to lift as material news takes place. Expecting some crazy share price swings for balance of the year.
Figured you would have deleted this after volume has been drying up. Down day continuation was a no brainer.
Margin account is different. Platform you are on is taking the risk that your trades properly close out during the T + X window. If anything does happen you simply get a call/notification similar to a margin call to find the account $X.
No generic availability since it’s not off patent yet, but others have already filed. We’re not first in line. Would be a year out at least when including prep to file + FDA review + launch.
Vyvanse and Concerta already have generic competition. That’s not news.
Wasn’t Derek = Couch?
Simply a waste of time, but to each their own. There is nothing expected to be approved for couple more months. Even then, those are table scrap ANDAs.
Why are you looking for an FDA approval? Nothing expected for another few months. Investors were waiting for BE results to be communicated.
Wow. This should be a sticky note. This commentary is truly is out of this world. 😀
Exactly. Latest 10K shows less than 35M let alone 1B. A billion dollar generic company? Not even close. What’s being smoked in that pipe?
Good commentary
Is jammy inching closer to execution sale price?
Wow, what garbage. That “analyst target” has been there for 10 years on CNN and hasn’t budged. Love the pumping, but I’d much rather see the BE results, good or bad.
Least time I checked that was the day after the cc. At the cc, CEO didn’t know final results and nothing has been communicated since.
Nothing has been divulged on BE results.
I believe Oxy is one of the 3 needlemovers
Kirko from sales
Schwab is significantly inferior to TD. Looking for a better platform.
Growing single digits isn’t going to get stock anywhere. Prasco will shake things up a bit with 2 larger ANDAs. We don’t know when last one will be filed yet. 2 smaller filings awaiting FDA approval now are non-news worthy. It rose on Prasco deal future growth news. I think there’s enough in pipeline and with Kirko driving sales that we can actually get consistent sequential growth. Would like to potentially see Kirko take over as CEO and keep Nasrat as chairman down road.
Maybe he thinks your birthdate is 2010. 😳
Really sad part is that the CEO communicated little north of 7M on last business day of quarter. He should have known exactly what sales were. Good thing there are no analysts covering this stock yet as they would have torn him a new one. That’s not underpromising and overdelivering. That’s either a statement of incompetence, not being as close to financials as he should be, or really crappy software. Take your pick.
We know FY24’s top line was to be at 40M and then now “north of $40M”. With Prasco AG deal starting 1/1 + newly minted relationships, let’s see them push this much higher.
You’d see the cash impact and it would be called out in financials. Can’t hide a transaction like that.
Lol I’m glad you like the drivel. Glad to hear someone reads it and enjoys it.
Did you actually read the article instead of insinuating? The use of AI for article writing is not quite where it needs to be to go mainstream and yet how many get suckered in believing everything they read on the internet. Those are the chaps I feel sorry for.
Strong Q2 results heading into Tuesday’s cc? What a bunch of crap. AI really sucks.
Completely agree with your comments. Yet on the flip side Bitcoin is worthless and yet trading for 30K? It’s in the eye of the buyer/seller to determine worth. I wouldn’t touch bitcoin with a 10 foot pole and yet others love trading it.
Nice to see the pub. Also says it polled 1 analyst for a “buy” rating. There are no analysts that cover elite. Guessing they are counting CNN’s AI as an analyst.
Some were far lower than that.
Buyback programs are always beneficial when grants and warrants are used. We may have a small period when we don’t incur either. As long as the intrinsic value is higher than market price, the buyback works in the company’s favor. You can always suspend a buyback program.
Agree + Covid did no favors for R&D. Was years of frustration. There were plenty of fumbles along the way by management, but with real growth those issues become harder to see.
The one thing that stood out for me on the call was his tone towards a stock repurchase. I wanted a $1M initial repurchase to help clean up excess float. Normally repurchase programs are multi-year deals. I think this is where his mind is going. Prasco AG wasn’t in the works previously and that cash flow generation will be a nice tailwind for both R&D and a nominal buyback.
I’d say we’re building a solid foundation with potential for growth after years of dilution to finally break even. It’s been a long ride. I can finally see that there are exciting days ahead. Last cc was a game changer. Still lots of unknowns, but company is finally making good strides forward vs 2 steps forward, 2 steps back maneuvers.
This is a penny stock, not Berkshire Hathaway.
Great to see out of the gate. Stronger volume than I expected. Would love to see the BE news to keep momentum going.
Huh?
Look at the volume traded throughout the morning vs afternoon. History is only a guide, not a tell all.
Volume was dying down yesterday afternoon. Wouldn’t be surprised if there was pullback if no news on BE.